Stanford University
Showing 101-120 of 175 Results
-
Andrew Philip Martella
Clinical Associate Professor, Radiation Oncology - Radiation Therapy
BioDr. Martella is a fellowship-trained radiation oncologist and a clinical assistant professor of radiation oncology at Stanford University School of Medicine.
His clinical interests include gynecologic, breast, thoracic, gastrointestinal, genitourinary, and central nervous system cancers. His experience encompasses the full range of radiotherapy techniques, including intensity modulated radiation therapy (IMRT), volumetric modulated arc therapy (VMAT), stereotactic body radiotherapy (SBRT), CyberKnife radiosurgery, eye plaque brachytherapy, and prostate and gynecologic high dose rate (HDR) brachytherapy.
Dr. Martella is dedicated to improving the quality of care and the patient experience. He deeply values a close relationship with his patients and their loved ones. He feels that each patient experiences healthcare in a unique and individual way. By recognizing and responding to those individual needs Dr. Martella provides a truly patient-centered experience. He has helped conduct research into noninvasive deep brain stimulation and chromosomal topography,and published on the topic of treating rectal cancer without radiation. He also was the primary contributing author of chapters in the book First Aid for the United States Medical Licensing Examination.
Dr. Martella has delivered presentations at the Annual Meeting of the American Society for Therapeutic Radiology and Oncology. Topics include chemotherapy and radiotherapy in endometrial cancer.
Among the honors for scholarship that Dr. Martella has received, he graduated first in his class at Duke University School of Medicine. He was also elected during medical school into Alpha Omega Alpha Honor Medical Society.
Dr. Martella’s community service has included a position on the board of directors of Camp Good Days and Special Times, a nonprofit organization that provides services for children who have cancer, have a parent or sibling with cancer, or have lost a parent or sibling to the disease. He has served on several leadership roles and has a deep dedication to furthering diversity and inclusion throughout the healthcare system. -
Everett J. Moding, MD, PhD
Assistant Professor of Radiation Oncology (Radiation Therapy)
Current Research and Scholarly InterestsMy laboratory performs translational research using analysis of human samples to identify critical mediators of treatment resistance that can be validated in preclinical models and targeted to enhance the efficacy of cancer therapy.
-
Sakib Mostafa
Postdoctoral Scholar, Radiation Physics
BioI am a Postdoctoral Research Fellow at Stanford University with a background in computational genomics and deep learning. My research focuses on developing AI-powered tools for genomic analysis, with a particular interest in cancer classification, pangenomes, and genotype imputation. Previously, I worked as a Research Officer at the National Research Council of Canada, contributing to large-scale sequencing projects and machine learning interfaces for biologists. I am passionate about bridging domain biology with cutting-edge computational methods to solve complex biological questions and drive innovation in precision agriculture and healthcare.
-
Prithvi Mruthyunjaya, MD, MHS
Alan Adler Professor of Ophthalmology and Professor, by courtesy, of Radiation Oncology
Current Research and Scholarly InterestsDr Mruthyunjaya has maintained a broad research interest with publications in both ocular oncology and retinal diseases.
His focus is on multi-modal imaging of ocular tumors and understanding imaging clues that may predict vision loss after ocular radiation therapy. He coordinates multi-center research on the role of genetic testing and outcomes of treatments of ocular melanoma.
In the field of retinal diseases, his interests are in intra-operative imaging to enhance surgical accuracy. -
Rohollah Nasiri
Postdoctoral Scholar, Radiation Physics
Current Research and Scholarly InterestsMy current research focuses on developing tumor-on-a-chip models for preclinical radiation therapy research.
